BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
86 hedge funds and large institutions have $153M invested in BioDelivery Sciences International, Inc. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 18 closing their positions.
268% more call options, than puts
Call options by funds: $420K | Put options by funds: $114K
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
37% more capital invested
Capital invested by funds: $112M → $153M (+$41.3M)
17% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 18
4% more funds holding
Funds holding: 83 → 86 (+3)
4% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$7.01M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.75M |
| 3 |
Millennium Management
New York
|
+$3.02M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$2.19M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$2.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$9.22M |
| 2 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
-$3.67M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$2.5M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.76M |
| 5 |
RA
Royce & Associates
New York
|
-$1.35M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Group One Trading
Chicago,
Illinois
| – | -$9.94K | -2,830 | Closed |
|
|
SPIA
102
Steward Partners Investment Advisory
New York
| – | -$1K | -500 | Closed |
|
BDSI Hedge Fund Activity: Q4 2018 in Review
86 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2018, worth a combined $153M — up 37% from $112M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new BDSI positions and 18 closed out — a net gain of 3 holders — while 23 added to existing stakes and 24 trimmed.
The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $7.01M. The largest seller was Armistice Capital, exiting entirely with an estimated $9.22M sold.
- 86 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2018, up from 83 in Q3 2018.
- Funds reported $153M of BioDelivery Sciences International, Inc. stock for Q4 2018, up 37% quarter-over-quarter.
- 21 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2018 and 18 closed out, a net change of +3 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q4 2018 was Rubric Capital Management (New York), an estimated $7.01M added.
- The largest BioDelivery Sciences International, Inc. seller in Q4 2018 was Armistice Capital, an estimated $9.22M sold.
Based on aggregated 13F filings for Q4 2018.